ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

DOW JONES NEWSWIRES Republicans on the House Energy and Commerce Committee are seeking information from several large drug companies about their agreements with the Obama administration during the formation of the health-care reform law, Bloomberg News reported Friday, citing three people familiar with the talks. One of the people said the Republicans turned to direct negotiations with the companies after trade group Pharmaceutical Research and Manufacturers of America didn't cooperate, Bloomberg reported. The committee is seeking documents and other information from Pfizer Inc. (PFE), Merck & Co. (MRK), Amgen Inc. (AMGN), Abbott Laboratories (ABT) and AstraZeneca PLC (AZN), Bloomberg reported. Rep. Michael Burgess (R., Texas) told Bloomberg that "this has been like pulling teeth, trying to get information." A spokesman for PhRMA said "we have been cooperating with the committee on an ongoing basis since the investigation began," Bloomberg reported. Full story at http://www.bloomberg.com/news/2012-05-04/obama-deal-with-drugmakers-said-to-be-probed-by-house.html -Dow Jones Newswires; 212-416-2900

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
07/31/201510:00:12U.S. Hot Stocks: Hot Stocks to Watch
07/31/201509:44:26U.S. Hot Stocks: Hot Stocks to Watch
07/30/201519:05:00Initial Statement of Beneficial Ownership (3)
07/30/201518:07:11Amgen Raises 2015 Outlook, Results Beat Expectations -- 2nd Update
07/30/201516:50:18Amgen Raises 2015 Outlook, Results Beat Expectations
07/30/201516:43:25Amgen Raises 2015 Outlook, Results Beat Expectations -- Update
07/30/201516:33:30Amgen Raises 2015 Outlook, Results Beat Expectations
07/30/201516:21:01Current Report Filing (8-k)
07/30/201516:05:00Amgen Announces Appointment Of Fred Hassan To Board Of Directors
07/30/201516:01:00Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4...
07/28/201517:46:00Amgen Announces 2015 Third Quarter Dividend
07/28/201512:26:16Merck Earnings Hurt by Arthritis Drug Knockoffs
07/27/201516:01:00Amgen Announces Webcast of 2015 Second Quarter Financial Results
07/24/201515:21:49Correction to Amgen/Kyprolis Article
07/24/201515:00:06FDA Approves Cholesterol Drug From Regeneron, Sanofi
07/24/201513:30:24FDA Approves Amgen's Kyprolis for Earlier Myeloma Treatment
07/24/201513:25:56FDA Approves Amgen's Kyprolis As a Second-Line Multiple Myeloma...
07/24/201512:40:00FDA Approves Kyprolis® (carfilzomib) For Combination Use In...
07/24/201509:10:04AbbVie's Revenue Growth Misses Expectations
07/24/201508:57:08AbbVie's Revenue Growth Misses Expectations

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad